GOECP/SEOR radiotherapy guidelines for thymic epithelial tumours

Table 1 Levels of evidence and grades of recommendation

Levels of evidence
I	Evidence from at least one large RCT of good methodological quality (low potential for bias) or meta-analyses of well-conducted randomised trials without heterogeneity
II	Small or large RCTs with suspicion of bias (lower methodological quality) or meta-analyses of such trials with demonstrated heterogeneity
III	Prospective cohort studies
IV	Retrospective cohort studies or case-control studies
V	Studies without control group, case reports, expert opinions
Grades of recommendation
A	Strong evidence for efficacy with a substantial benefit, strongly recommended
B	Strong or moderate evidence for efficacy but with a limited clinical benefit, generally recommended
C	Insufficient evidence for efficacy or benefit does not outweigh the risk or the disadvantages (adverse events, costs, etc.), optional
D	Moderate evidence against efficacy or for adverse outcome, generally not recommended
E	Strong evidence against efficacy or for adverse outcome, never recommended

RCT: Randomised controlled trial.